Chinese investment delegation sets sights on Korean bio companies
08-Dec-17, Business Korea
Chinese investors plan to solidify their positions in the global 4.0 Industry by directly investing in Korea's future industries such as biotech and information technology (IT) industries.
Image: Business Korea
KKR, a global private equity firm, and affiliates of China’s CITIC Securities want to invest in unlisted Korean bio companies.
"We hope that Korea's high-tech bio companies will enter China. China's policy, if investment is made," said a spokesperson for Spider Beijing Information Advisory, a Chinese investment advisory firm.